Evidence map›Paper›PMID 28213521›Full record

ArticleThe Journal of biological chemistry2017

Signaling adaptor ShcD suppresses extracellular signal-regulated kinase (Erk) phosphorylation distal to the Ret and Trk neurotrophic receptors.

Melanie K B Wills, Ava Keyvani Chahi, Hayley R Lau, Manali Tilak, Brianna D Guild, Laura A New, Peihua Lu, Kévin Jacquet, Susan O Meakin, Nicolas Bisson and 1 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.3field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Adaptor Protein ShcD/Molecular cancer research : MCR · 2021
    Article
  5. Receptor Tyrosine Kinase Signaling and Targeting in Glioblastoma Multiforme.International journal of molecular sciences · 2021
    Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Melanie K B WillsFrom the Department of Molecular and Cellular Biology, University of Guelph, Guelph, Ontario N1G 2W1, Canada.
Ava Keyvani ChahiFrom the Department of Molecular and Cellular Biology, University of Guelph, Guelph, Ontario N1G 2W1, Canada.
Hayley R LauFrom the Department of Molecular and Cellular Biology, University of Guelph, Guelph, Ontario N1G 2W1, Canada.
Manali TilakFrom the Department of Molecular and Cellular Biology, University of Guelph, Guelph, Ontario N1G 2W1, Canada.
Brianna D GuildFrom the Department of Molecular and Cellular Biology, University of Guelph, Guelph, Ontario N1G 2W1, Canada.
Laura A NewFrom the Department of Molecular and Cellular Biology, University of Guelph, Guelph, Ontario N1G 2W1, Canada.
Peihua LuFrom the Department of Molecular and Cellular Biology, University of Guelph, Guelph, Ontario N1G 2W1, Canada.
Kévin JacquetCancer Research Centre, Quebec Network for Research on Protein Function, Engineering, and Applications (PROTEO) and Centre Hospitalier Universitaire de Québec Research Centre-Université Laval, Québec City, Québec G1R 2J6, Canada, and.
Susan O MeakinDepartment of Biochemistry, Western University, London, Ontario N6A 5B7, Canada.
Nicolas BissonCancer Research Centre, Quebec Network for Research on Protein Function, Engineering, and Applications (PROTEO) and Centre Hospitalier Universitaire de Québec Research Centre-Université Laval, Québec City, Québec G1R 2J6, Canada, and.
Nina JonesFrom the Department of Molecular and Cellular Biology, University of Guelph, Guelph, Ontario N1G 2W1, Canada, jonesmcb@uoguelph.ca.
University of Guelph · CACentre hospitalier universitaire de Québec · CAUniversité Laval · CAWestern University · CA

Funding

CIHR
6 · The paper itself

Abstract

Proteins of the Src homology and collagen (Shc) family are typically involved in signal transduction events involving Ras/MAPK and PI3K/Akt pathways. In the nervous system, they function proximal to the neurotrophic factors that regulate cell survival, differentiation, and neuron-specific characteristics. The least characterized homolog, ShcD, is robustly expressed in the developing and mature nervous system, but its contributions to neural cell circuitry are largely uncharted. We now report that ShcD binds to active Ret, TrkA, and TrkB neurotrophic factor receptors predominantly via its phosphotyrosine-binding (PTB) domain. However, in contrast to the conventional Shc adaptors, ShcD suppresses distal phosphorylation of the Erk MAPK. Accordingly, genetic knock-out of mouse ShcD enhances Erk phosphorylation in the brain. In cultured cells, this capacity is tightly aligned to phosphorylation of ShcD CH1 region tyrosine motifs, which serve as docking platforms for signal transducers, such as Grb2. Erk suppression is relieved through independent mutagenesis of the PTB domain and the CH1 tyrosine residues, and successive substitution of these tyrosines breaks the interaction between ShcD and Grb2, thereby promoting TrkB-Grb2 association. Erk phosphorylation can also be restored in the presence of wild type ShcD through Grb2 overexpression. Conversely, mutation of the ShcD SH2 domain results in enhanced repression of Erk. Although the SH2 domain is a less common binding interface in Shc proteins, we demonstrate that it associates with the Ptpn11 (Shp2) phosphatase, which in turn regulates ShcD tyrosine phosphorylation. We therefore propose a model whereby ShcD competes with neurotrophic receptors for Grb2 binding and opposes activation of the MAPK cascade.

Indexed as

Amino Acid MotifsCell LineExtracellular Signal-Regulated MAP KinasesGRB2 Adaptor ProteinHumansMAP Kinase Signaling SystemMembrane GlycoproteinsPhosphorylationProtein-Tyrosine KinasesProtein Tyrosine Phosphatase, Non-Receptor Type 11Proto-Oncogene Proteins c-retReceptor, trkAReceptor, trkBShc Signaling Adaptor ProteinsExtracellular Signal-Regulated MAP KinasesGRB2 Adaptor ProteinGRB2 protein, humanMembrane GlycoproteinsNTRK1 protein, humanProtein-Tyrosine KinasesProtein Tyrosine Phosphatase, Non-Receptor Type 11Proto-Oncogene Proteins c-retPTPN11 protein, humanReceptor, trkAReceptor, trkBRET protein, humanSHC4 protein, humanShc Signaling Adaptor Proteinstropomyosin-related kinase-B, humanextracellular signal-regulated kinase (ERK)growth factor receptor-bound protein 2 (GRB2)neurotrophinphosphotyrosine adaptorRaLPShcDShp2signal transductionTRK1-transforming tyrosine kinase protein (Trk-A)TrkB

Identifiers

PMID28213521
PMCPMC5392570
OpenAlexW2589010019

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.